Market Currents
GlaxoSmithKline (GSK) says the FDA has approved its Fluarix Quadrivalent flu vaccine. Fluarix...
-
Monday, December 17, 2012, 10:43 AM ETGlaxoSmithKline (GSK) says the FDA has approved its Fluarix Quadrivalent flu vaccine. Fluarix Quadrivalent is the first intramuscular vaccine to cover against four influenza strains, and GSK plans to make it available in time for the 2013-14 flu season. Healthcare providers traditionally order flu vaccines a year in advance of each flu season.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
